IRIS
SARACINO, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.511
AS - Asia 7.541
EU - Europa 6.256
SA - Sud America 1.921
AF - Africa 415
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 31.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.140
SG - Singapore 3.104
IT - Italia 2.378
BR - Brasile 1.473
CN - Cina 1.401
HK - Hong Kong 1.093
DE - Germania 797
VN - Vietnam 636
SE - Svezia 619
RU - Federazione Russa 599
FR - Francia 468
FI - Finlandia 377
GB - Regno Unito 317
BD - Bangladesh 299
IN - India 226
UA - Ucraina 183
CA - Canada 181
AR - Argentina 153
CI - Costa d'Avorio 135
ID - Indonesia 131
MX - Messico 106
IQ - Iraq 97
NL - Olanda 96
ZA - Sudafrica 91
PK - Pakistan 80
PL - Polonia 78
EC - Ecuador 77
TR - Turchia 70
JP - Giappone 62
VE - Venezuela 57
CO - Colombia 56
AT - Austria 54
ES - Italia 52
BE - Belgio 51
SA - Arabia Saudita 50
PH - Filippine 43
MA - Marocco 38
IE - Irlanda 36
CL - Cile 32
TN - Tunisia 30
KE - Kenya 29
LT - Lituania 27
JO - Giordania 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 23
MY - Malesia 23
PY - Paraguay 22
JM - Giamaica 21
PE - Perù 20
CH - Svizzera 15
IL - Israele 15
KZ - Kazakistan 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
CR - Costa Rica 14
DZ - Algeria 14
ET - Etiopia 14
PS - Palestinian Territory 14
TW - Taiwan 12
EG - Egitto 11
GR - Grecia 11
HR - Croazia 11
LY - Libia 11
NP - Nepal 11
RS - Serbia 11
UY - Uruguay 11
AU - Australia 10
BO - Bolivia 10
TT - Trinidad e Tobago 10
KW - Kuwait 8
LB - Libano 8
PA - Panama 8
AL - Albania 7
OM - Oman 7
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
HU - Ungheria 6
IR - Iran 6
KR - Corea 6
NG - Nigeria 6
QA - Qatar 6
RO - Romania 6
SR - Suriname 6
HN - Honduras 5
NI - Nicaragua 5
PT - Portogallo 5
SV - El Salvador 5
TH - Thailandia 5
UG - Uganda 5
DO - Repubblica Dominicana 4
EU - Europa 4
GE - Georgia 4
GH - Ghana 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
MZ - Mozambico 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
Totale 31.599
Salva come PNG Salva come JPEG
Città #
Ashburn 1.833
Singapore 1.740
Fairfield 1.561
Hong Kong 1.087
Woodbridge 1.037
San Jose 945
Houston 780
Chandler 709
Milan 709
Seattle 669
Cambridge 534
Wilmington 517
Dallas 485
Ann Arbor 476
Nyköping 472
Beijing 467
New York 385
Jacksonville 384
Rome 287
Munich 285
Lauterbourg 283
Los Angeles 276
Helsinki 219
Council Bluffs 185
Lawrence 180
Roxbury 179
Boardman 177
Ho Chi Minh City 173
Nanjing 173
Columbus 146
Abidjan 135
São Paulo 134
Hanoi 130
Santa Clara 127
Falkenstein 125
Bari 124
Buffalo 123
Des Moines 109
Jakarta 88
Princeton 88
London 80
Brooklyn 74
Frankfurt am Main 72
Chicago 70
Dong Ket 68
Montreal 66
San Diego 66
Inglewood 65
Figino 64
Warsaw 62
Atlanta 57
Tokyo 56
Turin 51
Mexico City 47
Moscow 47
Stockholm 45
Toronto 45
Brussels 44
Orem 44
Rio de Janeiro 44
Denver 42
Johannesburg 42
Turku 42
Hebei 40
Nuremberg 38
San Francisco 37
Shenyang 36
Chennai 34
Curitiba 34
Dublin 34
Paris 32
Nanchang 31
Naples 31
Jiaxing 30
Belo Horizonte 29
Phoenix 29
Baghdad 26
Mumbai 26
Tianjin 26
Brasília 25
Lahore 25
Quito 25
Salt Lake City 25
Da Nang 24
Dearborn 24
Amsterdam 23
Guayaquil 23
Pune 23
Haiphong 22
Nairobi 22
Palermo 22
Tashkent 22
The Dalles 22
Boston 21
Guangzhou 21
Poplar 21
Vienna 21
Amman 20
Ankara 20
Düsseldorf 20
Totale 20.813
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 417
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 378
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 367
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 241
First Case of Paraphimosis as a Severe Complication of Monkeypox 240
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 226
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 208
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 201
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 196
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 192
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 192
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 186
An outbreak of HIV-1 BC recombinants in Southern Italy 183
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 179
Potential diagnostic properties of chest ultrasound in thoracic tuberculosis—A systematic review 177
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 176
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 176
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study 175
A 75-year-old woman presenting with nasal vestibulitis 174
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 170
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 169
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 166
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 164
The elderly and direct antiviral agents: Constraint or challenge? 162
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 161
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study 159
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 159
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study. 158
A 75-year-old woman presenting with nasal vestibulitis 157
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 155
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 153
Co-receptor switch during HAART is independent of virological success 151
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 151
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 150
First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging Yeast 149
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 149
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 149
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 148
Splenic abscesses as a first manifestation of Crohn's disease: A case report 148
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 147
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 147
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. 146
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 146
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review 145
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 145
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 145
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 144
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study 144
Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique 144
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 143
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 142
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 142
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 141
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 140
The at risk child clinic (ARCC): 3 years of health activities in support of the most vulnerable children in Beira, Mozambique 140
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 139
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 139
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 138
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 137
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? 137
Are the proposed env mutations actually associated with resistance to maraviroc? 137
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 137
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 136
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 135
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 135
Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19 135
A Challenging Case of Visceral Leishmaniasis 134
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 134
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 134
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 133
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 132
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 132
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 131
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections 130
Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: a cross-sectional study 130
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 129
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 129
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? 129
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 128
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 127
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 127
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 127
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 126
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 126
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 126
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 126
Multidisciplinary Approach in the Treatment of Descending Necrotizing Mediastinitis: Twenty-Year Single-Center Experience 126
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 125
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 125
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program 124
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance and Herpesvirus Reactivation: A Double Face of Janus? 124
Predictors of therapy failure in newly diagnosed pulmonary tuberculosis cases in Beira, Mozambique. 124
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 123
Tuberculosis and diabetes: Current state and future perspectives 122
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 122
Monkeypox Virus Infections in Southern Italy: Is There a Risk for Community Spread? 120
Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients 120
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 120
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 120
Pathways of care for HIV infected children in Beira, Mozambique: Pre-post intervention study to assess impact of task shifting 120
Totale 15.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.309 86 158 21 61 52 106 81 91 82 93 183 295
2022/20232.087 316 204 150 143 225 293 39 285 311 18 57 46
2023/20241.149 80 216 68 88 111 277 37 42 28 36 40 126
2024/20254.991 125 93 314 142 99 423 542 516 263 344 656 1.474
2025/202614.586 1.611 791 1.141 1.689 1.530 853 1.374 452 1.574 1.378 630 1.563
2026/2027561 561 0 0 0 0 0 0 0 0 0 0 0
Totale 32.932